CRO & Clinical Services

Micronic is an independent, ISO 9001 and ISO 14001 certified manufacturer of sample storage tubes, racks and equipment headquartered in Lelystad, the Netherlands. It supplies coded and uncoded tubes, racks, caps, barcode readers and (de)capping tools that support automated, high-integrity sample preservation for hospitals, pharma, biotech and research labs worldwide. Micronic also offers eco-friendly racks, configuration tools, webinars and customer-focused technical support.

Micropep is a Toulouse-based ag-biotech company developing sustainable crop-protection solutions using micropeptides. Its platform combines AI, bioproduction, and delivery technologies, and public materials highlight bioherbicide development, including a collaboration with FMC.

BMG LABTECH is an independent microplate reader specialist offering absorbance, fluorescence, luminescence, nephelometry, and multi-mode systems. It serves pharma, CRO, and research buyers needing high-throughput, flexible optical detection for assay development and drug discovery.

Microplates (Porvair Sciences) supplies high-quality microplates, porous plastics, seals and automation-friendly instruments for life science and pharmaceutical labs. The company also offers custom manufacturing, OEM partnerships and technical resources supporting applications from sample preparation and SPE to drug discovery, cancer research and immunology/ELISA workflows.

Leica Microsystems provides microscopy, imaging, and analysis solutions for research, industrial inspection, and surgical visualization. Its official site highlights research microscopes, advanced imaging platforms, AI image analysis software, and specialty surgical visualization tools.

MitoRx Therapeutics is a preclinical-stage biotechnology company developing first-in-class mitochondrial-targeted sulfide-donor and small molecule therapeutics for high-risk obesity and myopathies. Their lead asset MTRX31 restores healthy mitochondrial metabolism to deliver durable, high-quality weight loss, preserve lean mass and regress organ fat, positioning the platform for broad cardiometabolic and degenerative disease applications.

Molecular Devices provides advanced bioanalytical instruments, software, and automated workflows for complex biology, high-content imaging, organoid research, and GxP-compliant labs. Their portfolio spans SpectraMax microplate readers, ImageXpress HCS.ai systems, CellXpress.ai automated cell culture, organoid expansion services, QPix FLEX colony pickers, and ELISA workcells for high-throughput drug discovery and life science research.

Nanion Technologies is a Munich-based provider of electrophysiology and cell analytics instrumentation for drug discovery and research. Its portfolio covers automated patch clamp, membrane biophysics, consumables, and support services for academic, CRO, and pharma buyers.

Nanoworx is a Netherlands-based CRO specializing in advanced nanomedicine development. It offers nanoparticle design, high-throughput screening, scale-up, manufacturing, and in vitro characterization for academic and industry clients.

Ncardia is a global iPSC technology company supplying iPSC-derived cell models, cardiac and neural assays, and custom iPSC platforms for drug discovery and cell therapy. With products like Ncyte® vCardiomyocytes and multi-tissue IO safety panels, it supports more predictive screening, long-term lot consistency and scalable manufacturing for pharma and biotech R&D.

Nemesys and Cobomation by CETONI deliver modular syringe pump–based flow systems and automation solutions built around the CETONI Elements software platform. Their Nemesys pumps provide pulseless, sub-nanoliter liquid dosing for microfluidics and precision dosing across biology, chemistry, geology and industrial applications. With configurable modules, accessories and SDK-based integration, CETONI targets customers needing customized, tightly integrated microfluidic and dosing workflows.

CETONI GmbH (Nemesys and Cobomation) is a German provider of high‑precision syringe pumps, modular microfluidic flow systems and automation solutions for research and industrial dosing. Its Nemesys S, M and ultra‑high‑pressure modules deliver pulsation‑free flow from sub‑nanoliter dosing up to 1000 bar, all controlled via CETONI Elements software and integrable through the CETONI SDK.

Neurolentech is an Austrian biotech spin-out from IST Austria that develops patient-derived neuronal cell models to accelerate drug discovery for neurodevelopmental disorders such as epilepsy, severe autism and intellectual disability. Using iPSC-based brain cell models and proprietary functional assays, the company identifies new drug targets and supports biopharma partners with disease-relevant screening platforms and collaborative NDD research.

Objective Biotechnology is a private biotechnology tools company in Minneapolis developing automated microinjection and neurotechnology platforms for high-throughput genetic and neuroscience research. Its Autoinjector robotic system uses computer vision and machine learning to automate embryo microinjection across species, while its neurotechnology tools provide cortex-wide optical access and recordings in unrestrained rodent models.

Optibrium is a private UK-based software company that provides StarDrop™, Cerella™ and BioPharmics™ to accelerate small-molecule drug discovery. Its intuitive, modular platform supports data analysis, SAR interpretation, compound generation, molecular design, macrocycle modelling and AI-guided optimisation, with real-time collaboration and rapid onboarding for medicinal chemistry and R&D teams.

Optibrium is a private, Cambridge-based software company providing AI-enabled platforms for small-molecule drug discovery, including the StarDrop modular discovery platform, Cerella AI-guided prediction engine and BioPharmics 3D molecular modelling solution. Its tools support medicinal chemistry teams with data analysis, molecular design, compound optimisation and real-time collaboration from hit identification through candidate selection, backed by scientifically validated methods and specialist PhD-level

Cyprumed GmbH is an Innsbruck-based drug delivery technology company specializing in proprietary oral peptide and biologic delivery platforms, including intestinal, gastric and BCS Class IV tablet technologies. It collaborates with major pharma companies such as MSD, Bayer, Boehringer Ingelheim and Ferring to transform injectable peptides and other complex molecules into scalable, orally bioavailable drug products.

CN Bio is a private UK organ-on-a-chip company offering PhysioMimix, a microphysiological system for human-relevant drug discovery. It supports single-organ, multi-organ, and higher-throughput studies across efficacy, ADME, safety, and toxicology, and the company says the platform has FDA ISTAND recognition and regulatory-use precedent.

MIMETAS is an organ-on-a-chip specialist providing human tissue models on its OrganoPlate® platform for drug discovery, safety testing, and disease research. The company supplies scalable 3D microphysiological systems, UniFlow pumpless flow technology, and ready-to-use models and services that deliver more predictive, human-relevant data across multiple therapeutic areas.

Oxford Nanopore Technologies plc develops nanopore-based DNA and RNA sequencing platforms, from portable devices like MinION to high-throughput systems, supported by library preparation kits and analysis workflows such as EPI2ME. Its research-use solutions enable real-time, short-to-ultra-long read sequencing and targeted panels, including the Oxford Nanopore Hereditary Cancer Panel, for genomics, microbiology, oncology and broader life science applications.

PHC Holdings Corporation is a Tokyo-based public healthcare group that leads PHC Group, offering diabetes management, life-science instruments, diagnostics, clinical testing, CRO services, and healthcare IT solutions in over 120 countries. Its subsidiaries provide ultra-low freezers, CO2 incubators, CGT tools, pathology systems, POCT devices, and digital health platforms that support pharma and biotech R&D, clinical trials, and routine care.

PacBio is a public sequencing company specializing in long-read and HiFi sequencing for research and clinical research applications. Its flagship Revio platform, plus consumables, prep kits, and software, support genome, transcriptome, epigenome, and microbiome workflows.

PAL System, developed by CTC Analytics in Switzerland, provides modular robotic platforms for automated sample preparation in GC, LC and MS workflows. Its PAL RSI, RTC and DHR systems support techniques such as LLE, SPME, µSPE and Dynamic Headspace, enabling turnkey, application-specific workflows for food, environmental, life science and pharmaceutical labs. The platforms improve throughput, data quality and safety while offering full electronic traceability and advanced capabilities such as PFAS analysis

Panome Bio is a St. Louis–based multi-omics CRO offering next-generation metabolomics, discovery proteomics, transcriptomics and integrated multi-omics services for biomarker discovery and mechanistic insight. Using advanced LC/MS and proprietary tools like its MassID engine, it delivers untargeted, high-depth metabolomics and proteomics data plus integrated analyses and curated reports for pharma, biotech and research customers.